Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma:
Condition(s):Meningioma; Radiation ToxicityLast Updated:September 14, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Meningioma; Radiation ToxicityLast Updated:September 14, 2023Recruiting
Condition(s):MeningiomaLast Updated:October 12, 2022Recruiting
Condition(s):Renal TumorLast Updated:May 9, 2023Recruiting
Condition(s):Locally Recurrent Prostate CancerLast Updated:November 18, 2023Recruiting
Condition(s):Colorectal Cancer Stage IV; No Evidence of Disease StateLast Updated:May 17, 2023Recruiting
Condition(s):NSCLCLast Updated:October 13, 2022Not yet recruiting
Condition(s):Radiotherapy Side Effect; Non-small Cell Lung Cancer; ALK Gene MutationLast Updated:October 10, 2023Recruiting
Condition(s):To Evaluate the Rate of Digestive and Urinary ToxicityLast Updated:October 17, 2023Recruiting
Condition(s):Prostate Cancer; Prostate Cancer Recurrent; Prostate Cancer Metastatic; Metastatic Cancer; OligometastasisLast Updated:February 28, 2024Recruiting
Condition(s):Prostate Cancer; Prostatic Cancer; Prostate Neoplasms; Prostatic Neoplasms; Cancer of the ProstateLast Updated:July 12, 2019Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.